MYO15A and hearing loss disorder: This indicated that the length of the mini-Myo15 promoter makes it possible to facilitate AAV-mediated gene therapy for 94.7% of the HC-expressed genes that are related to recessive nonsyndromic hearing loss (Table S1 and Fig. S6).